|
|
|
|
Glycemic index, glycemic load, and risk of digestive tract neoplasms: A systematic review and meta-analysis
Studies that examined the risk between GI or GL intake and colorectal cancer, and adenomas, pancreatic cancer, gastric cancer, and squamous-cell esophageal carcinoma were retrieved Positive associations between GI and GL intake...
|
|
|
'Hormone imbalance' raises question of cancer
but survived.The hormone problem may signal recurrence, some doctors suggest. By Shari Roan January 6, 2009 Pancreatic cancer has a dismal survival rate, surely one reason the business world has been abuzz in recent weeks over the gaunt...
|
|
|
Experts Weigh in on Steve Jobs' Disclosure of Hormonal Imbalance
from a health information Web site for patients Miranda Hitti January 5, 2009 Steve Jobs today posted a letter on the Apple web site stating that he has a 'hormonal imbalance' that caused him to lose weight throughout 2008, and that he's...
|
|
|
Steve Jobs' Hormonal Imbalance: FAQ
5, 2009 -- Steve Jobs today posted a letter on the Apple web site stating that he has a 'hormonal imbalance' that caused him to lose weight throughout 2008, and that he's being treated and staying on the job as Apple's CEO.In 2004, Jobs...
|
|
|
Steve Jobs' weight loss may be linked to his earlier cancer, medical experts say
In this Oct.14, 2008 file photo, Apple's Steve Jobs unveiled new laptops at the company's headquarters in Cupertino. (MARIA J. AVILA/MERCURY NEWS) Apple CEO Steve Jobs' recent weight loss may be linked to his prior surgery for...
|
|
|
Apple CEO Cites 'Hormonal Imbalance' in Puzzling Weight Loss
CUPERTINO, Calif., Jan.5 -- With the future of one of the nation's most glamorous companies riding on a prognosis, Steve Jobs, the co-founder and chief executive of Apple, announced today that he is not dying -- rumors and appearances to...
|
|
|
Conference on cell therapy includes new session on stem cells for non-cardiac organ injury
The Fifth International Conference on Cell Therapy for Cardiovascular Disease (IC3D) will include a new session on stem cells for non-cardiac organ injury.The session will include new data on stem cells for islet...
|
|
|
CellCyte Genetics Corp. Says Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly reported that CellCyte 'closes.' In CellCyte's August 14, 2008 press release, the Company reported progress in its bioreactor...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) reports that a December 24, 2008 article published by the reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly reported that...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG - News) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (CCYG) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 WA-CellCyte-Genetics BOTHELL, Wash., Dec. 29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) reports that a December 24, 2008 article published by the Seattle Times...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
NEWS RELEASE CellCyte Genetics Corporation Announces Progress in its Device Division and Revised Plans for the Development of its Therapeutic Product Candidates August 14, 2008 'We have been successful in expanding a human hematopoietic ...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports
NEWS RELEASE CellCyte Genetics CorporationAnnounces Progress in its Device Division andRevised Plansfor theDevelopment ofits TherapeuticProductCandidates August 14, 2008 'We have been successful in expanding a human hematopoietic cell...
|
|
|
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
BOTHELL, Wash., Dec.29 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) reports that a December 24, 2008 article published by the Seattle Times reporting on CellCyte's third quarter 2008 SEC 10Q filing incorrectly...
|
|
|
Characterization of Pancreatic Ductal Cells in Human Islet Preparations
_ Characterization of Pancreatic Ductal Cells in Human Islet Preparations.
|
|
|
A Multi-Year Analysis of Islet Transplantation Compared With Intensive Medical Therapy on Progression of Compl
Background.We hypothesized that transplantation of islets into type 1 diabetics could improve outcomes of glucose metabolism, renal function, retinopathy, and neuropathy compared with intensive medical therapy. Methods. We...
|
|
|
Islet Autotransplant Outcomes After Total Pancreatectomy: A Contrast to Islet Allograft Outcomes
Introduction.Islet allografts are currently associated with a high rate of early insulin independence, but after 1 year insulin-independence rates rapidly decline for unclear reasons. In contrast, as shown here, islet...
|
|
|
Osiris Therapeutics to Present at 27th Annual J.P. Morgan Healthcare Conference
- Osiris Therapeutics, Inc.(NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas, announced today...
|
